Related Articles
Selective gene transfer to tumor cells by recombinant Newcastle Disease Virus via a bispecific fusion protein
In vivo efficacy of systemic tumor targeting of a viral RNA vector with oncolytic properties using a bispecific adapter protein
Optimization studies for the coupling of bispecific antibodies to viral anchor molecules of a tumor vaccine
Effective introduction of T cell costimulatory molecules into virus modified tumor cell vaccines by modification with bispecific antibodies
Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity